My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 141

    1.

    Vasodilator therapy for primary pulmonary hypertension. Limitations and hazards.

    Packer M.

    Ann Intern Med. 1985 Aug;103(2):258-70. Review.PMID: 2861770 [PubMed - indexed for MEDLINE]Related articles

    2.

    Vasodilator therapy for primary pulmonary hypertension.

    McGoon MD, Vlietstra RE.

    Mayo Clin Proc. 1984 Oct;59(10):672-7. Review.PMID: 6148467 [PubMed - indexed for MEDLINE]Related articles

    3.

    [Evaluation of the effects of vasodilator therapy in primary pulmonary hypertension. Experience in 7 cases]

    Lanzarini L, Gavazzi A, Mussini A, Graziano G, Campana C, Bargiggia G, Angoli L, Aimè E, Arbustini E, Montemartini C.

    G Ital Cardiol. 1990 Feb;20(2):114-22. Italian. PMID: 2328864 [PubMed - indexed for MEDLINE]Related articles

    4.

    Therapeutic application of calcium-channel antagonists for pulmonary hypertension.

    Packer M.

    Am J Cardiol. 1985 Jan 25;55(3):196B-201B. Review.PMID: 3881914 [PubMed - indexed for MEDLINE]Related articles

    5.

    Primary pulmonary hypertension: Current therapy.

    Sitbon O, Humbert M, Simonneau G.

    Prog Cardiovasc Dis. 2002 Sep-Oct;45(2):115-28. Review.PMID: 12411973 [PubMed - indexed for MEDLINE]Related articles

    6.

    Vasodilatory treatment of pulmonary hypertension.

    Widimský J.

    Eur J Respir Dis. 1986 Mar;68(3):161-6.PMID: 2870937 [PubMed - indexed for MEDLINE]Related articles

    7.

    Selective pulmonary and systemic vasodilator effects of amrinone in children: new therapeutic implications.

    Robinson BW, Gelband H, Mas MS.

    J Am Coll Cardiol. 1993 May;21(6):1461-5.PMID: 8473656 [PubMed - indexed for MEDLINE]Related articles

    8.

    Profile of paediatric patients with pulmonary hypertension judged by responsiveness to vasodilators.

    Houde C, Bohn DJ, Freedom RM, Rabinovitch M.

    Br Heart J. 1993 Nov;70(5):461-8.PMID: 8260279 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Vasodilator therapy for primary pulmonary hypertension.

    Palevsky HI, Fishman AP.

    Annu Rev Med. 1985;36:563-78. Review. No abstract available. PMID: 2859832 [PubMed - indexed for MEDLINE]Related articles

    10.

    Comparative immediate hemodynamic and hormonal effects of amrinone and captopril in patients with severe chronic heart failure.

    Packer M, Medina N, Yushak M.

    Am J Med Sci. 1986 Jan;291(1):8-15.PMID: 3510545 [PubMed - indexed for MEDLINE]Related articles

    11.

    Comparative actions of hydralazine, nifedipine and amrinone in primary pulmonary hypertension.

    Rich S, Ganz R, Levy PS.

    Am J Cardiol. 1983 Nov 1;52(8):1104-7.PMID: 6637831 [PubMed - indexed for MEDLINE]Related articles

    12.

    Inhaled nitric oxide in primary pulmonary hypertension: a safe and effective agent for predicting response to nifedipine.

    Ricciardi MJ, Knight BP, Martinez FJ, Rubenfire M.

    J Am Coll Cardiol. 1998 Oct;32(4):1068-73.PMID: 9768734 [PubMed - indexed for MEDLINE]Related articles

    13.

    Treatment of pulmonary hypertension.

    Denolin H, Mathey DG.

    Herz. 1986 Jun;11(3):169-75.PMID: 2875021 [PubMed - indexed for MEDLINE]Related articles

    14.

    Hemodynamic and clinical limitations of long-term inotropic therapy with amrinone in patients with severe chronic heart failure.

    Packer M, Medina N, Yushak M.

    Circulation. 1984 Dec;70(6):1038-47.PMID: 6388899 [PubMed - indexed for MEDLINE]Related articles

    15.

    Inhaled prostacyclin and iloprost in severe pulmonary hypertension secondary to lung fibrosis.

    Olschewski H, Ghofrani HA, Walmrath D, Schermuly R, Temmesfeld-Wollbruck B, Grimminger F, Seeger W.

    Am J Respir Crit Care Med. 1999 Aug;160(2):600-7.PMID: 10430735 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    The pathophysiology and management of primary pulmonary hypertension.

    Fein SA, Frishman WH.

    Cardiol Clin. 1987 Nov;5(4):563-76. Review.PMID: 2900068 [PubMed - indexed for MEDLINE]Related articles

    17.

    Vasoresponsiveness of sarcoidosis-associated pulmonary hypertension.

    Preston IR, Klinger JR, Landzberg MJ, Houtchens J, Nelson D, Hill NS.

    Chest. 2001 Sep;120(3):866-72.PMID: 11555522 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    [Management of pulmonary circulation alterations]

    Quero Jiménez MC, Burgueros Valero M, González Dieguez C, Domínguez Pérez F, Pinto Corraliza J, Rodríguez Fernández M.

    Rev Esp Cardiol. 1993;46 Suppl 2:13-28. Review. Spanish. No abstract available. PMID: 7905203 [PubMed - indexed for MEDLINE]Related articles

    19.

    Pharmacotherapy of chronic pulmonary arterial hypertension: value and limitations. Part I: Primary pulmonary hypertension.

    Alpert MA, Concannon MD, Mukerji B, Mukerji V.

    Angiology. 1994 Aug;45(8):667-76. Review.PMID: 7914075 [PubMed - indexed for MEDLINE]Related articles

    20.

    Adverse hemodynamic and clinical effects of calcium channel blockade in pulmonary hypertension secondary to obliterative pulmonary vascular disease.

    Packer M, Medina N, Yushak M.

    J Am Coll Cardiol. 1984 Nov;4(5):890-901.PMID: 6491082 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity